In this study, we explored the relationship between MVP expression in PAAD and the pharmacological efficacy of both (Food and Drug Administration) FDA-approved and clinically evaluated drugs using the data of RNA-seq and compound activity accessed from CellMiner. Here, MVP is linked to pancreatic adenocarcinoma.